Meeting
2018 Gastrointestinal Cancers Symposium
Detection and description of ERBB2 amplification using circulating cell free tumor DNA (ctDNA) genomic analysis in metastatic colorectal cancer (mCRC).
Authors
Kanwal Pratap Singh Raghav
University of Texas MD Anderson Cancer Center, Houston, TX
Kanwal Pratap Singh Raghav , Jonathan M. Loree , Jeffrey Morris , Shanequa Manuel , Shadarra Crosby , Funda Meric-Bernstam , David Menter , Victoria Raymond , Richard B. Lanman , AmirAli Talasaz , Scott Kopetz
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session C: Cancers of the Colon, Rectum, and Anus
Track
Cancers of the Colon, Rectum, and Anus
Sub Track
Translational Research
Citation
J Clin Oncol 36, 2018 (suppl 4S; abstr 661)
DOI
10.1200/JCO.2018.36.4_suppl.661
Abstract #
661
Poster Bd #
E22
Abstract Disclosures
Similar Posters
Poster
2019 ASCO Annual Meeting
Genomic alterations after EGFR blockade in patients with RAS wild-type metastatic colorectal cancer: Combined tissue and blood-based analysis from SCRUM-Japan GI-SCREEN and GOZILA.
First Author: Yoshiaki Nakamura
Poster
2023 ASCO Gastrointestinal Cancers Symposium
Circulating tumor DNA–based genomic landscape of KRAS wild-type pancreatic adenocarcinoma.
First Author: Brendon Fusco
Poster
2023 ASCO Gastrointestinal Cancers Symposium
Genomic landscape of acquired resistance to targeted therapies in metastatic colorectal cancer (mCRC).
First Author: Emily Harrold
Poster
2023 ASCO Gastrointestinal Cancers Symposium
A plasma-based analysis and genomic landscape of patients with high tumor mutational burden (TMB-H), microsatellite stable (MSS) colorectal cancer (CRC).
First Author: Anwaar Saeed